Patents by Inventor Lars Ohman

Lars Ohman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GOLEXANOLONE FOR USE IN THE TREATMENT OF FATIGUE OR COGNITIVE IMPAIRMENT IN LIVER DISEASE PATIENTS
    Publication number: 20240216394
    Abstract: The present invention is directed to the compound golexanolone or a pharmaceutically acceptable salt thereof for use in the treatment of fatigue or cognitive impairment, or a combination thereof, in a non-cirrhotic patient with a chronic liver disease, wherein the patient has a serum level of allopregnanolone which is 0.03 ng/ml or higher.
    Type: Application
    Filed: April 19, 2022
    Publication date: July 4, 2024
    Inventors: Magnus Doverskog, Maja Johansson, Lars Öhman, David Jones
  • Estrogen receptor ligands
    Publication number: 20040093165
    Abstract: A system and method for generating a mask layout file to eliminate antenna effects in an integrated circuit are disclosed. The method includes analyzing a pattern in a mask layout file to identify a region including an antenna ratio less than a first design rule. A feature located in the identified region is moved based on a second design rule from a first position to a second position in the mask layout file. A grounding feature is placed in the space and automatically connected to a gate feature in the mask layout file such that the antenna ratio is increased to greater than or approximately equal to the first design rule.
    Type: Application
    Filed: March 18, 2003
    Publication date: May 13, 2004
    Inventors: Lars Ohman, Tomas Bonn, Mats Carlquist, Owe Engstrom, Patrick Goede, Asa Hedfors, Erik Holmgren, Konrad F. Koehler, Andrzej M. Brzozowski, Ashley C.W. Pike, Roderick E. Hubbard
  • Estrogen receptor ligands
    Publication number: 20030032779
    Abstract: The present invention is directed to crystals comprising at least part of the estrogen receptor &agr; (ER&agr;) ligand binding domain, optionally bound to a ligand. The present invention is also directed to ligands that bind to ER receptors, and method of designing them. The present invention is also directed to a homology model of the ER&bgr; receptor.
    Type: Application
    Filed: June 5, 2002
    Publication date: February 13, 2003
    Inventors: Lars Ohman, Tomas Bonn, Mats Carlquist, Owe Engstrom, Patrick Goede, Asa Hedfors, Erik Holmgren, Konrad F. Koehler, Andrzej M. Brzozowski, Ashley C.W. Pike, Roderick E. Hubbard
  • Culture medium for insect cells
    Publication number: 20010009767
    Abstract: The present invention is directed to a culture medium for insect cells, particularly for culturing insect cells for the expression of proteins using a baculovirus expression system, characterized in that the medium does not contain glutamine.
    Type: Application
    Filed: January 19, 2001
    Publication date: July 26, 2001
    Inventors: Lars Ohman, Lena Haggstrom
  • Culture medium for insect cells lacking glutamine an contains ammonium salt
    Patent number: 6210966
    Abstract: A culture medium for growth of insect cells, such as Spodoptera frugiperda, is provided. The culture medium lacks glutamine, and may optionally lack glutamate and/or aspartate. Further the insect culture medium contains an ammonium ion source, such as an ammonium salt. The culture medium is particularly useful for culturing the insect cells for a variety of purposes, for example, producing proteins or polypeptides using a baculovirus expression system.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: April 3, 2001
    Assignee: Karo Bio AB
    Inventors: Lars Öhman, Lena Häggström